School of Basic Pharmaceutical and Toxicological Sciences,
College of Pharmacy,
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy
George Mattheolabakis has not added Biography.
If you are George Mattheolabakis and would like to personalize this page please email our Author Liaison for assistance.
Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticles.
International journal of oncology Oct, 2017 | Pubmed ID: 28849098
Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice.
Archives of biochemistry and biophysics Jun, 2018 | Pubmed ID: 29679536
Non-viral based miR delivery and recent developments.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Jul, 2018 | Pubmed ID: 29679644
Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
Scientific reports Jul, 2018 | Pubmed ID: 30002440
Evaluation of the feasibility of intrapancreatic delivery of drug-loaded microparticles via EUS-guided fine needle injection using a swine model.
Endoscopy international open Aug, 2019 | Pubmed ID: 31404394
Cellular Migration Assay: An In Vitro Technique to Simulate the Wound Repair Mechanism.
Methods in molecular biology (Clifton, N.J.) , 2021 | Pubmed ID: 32808260
A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.
European journal of medicinal chemistry Apr, 2021 | Pubmed ID: 33667849
Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance.
Scientific reports Mar, 2021 | Pubmed ID: 33753779
Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery.
Pharmaceutics Nov, 2022 | Pubmed ID: 36559106
Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles.
The Journal of pharmacology and experimental therapeutics Apr, 2023 | Pubmed ID: 36746610
Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer.
International journal of pharmaceutics May, 2023 | Pubmed ID: 37059241
A K M Nawshad Hossian1,
Chandra Mohan Reddy Muthumula1,
Md. Sanaullah Sajib2,
Paul E. Tullar3,
April M. Stelly1,
Karen P. Briski1,
Constantinos M. Mikelis2,
George Mattheolabakis1
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe,
2Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center,
3Department of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center
Racheal Grace Akwii*,1,
Margarita Lamprou*,2,
Maria Georgomanoli3,
Andriana Plevriti2,
Antonia Marazioti4,
Athanasia Mouzaki5,
George Mattheolabakis6,
Constantinos M. Mikelis1,2
1Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center,
2Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras,
3Division of Flow Cytometry and Division of MDx & Life Sciences, SB BioAnalytica,
4Basic Sciences Laboratory, Department of Physiotherapy, University of Peloponnese,
5Division of Hematology, Department of Internal Medicine, Medical School, University of Patras,
6School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유